Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Catalyst Pharmaceutical Partners Inc buy Citigroup Inc.

Catalyst Pharmaceutical Partners Inc
Start price
€15.01
14.03.24 / 50%
Target price
€24.74
14.03.25
Performance (%)
26.78%
End price
€19.03
15.03.25
Summary
This prediction ended on 15.03.25 with a price of €19.03. The prediction had a final performance of 26.78%. Citigroup_Inc_ has a follow-up prediction for Catalyst Pharmaceutical Partners Inc where he still thinks Catalyst Pharmaceutical Partners Inc is a Buy. Citigroup_Inc_ has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Catalyst Pharmaceutical Partners Inc 0.571% 0.571% -14.017%
iShares Core DAX® -0.917% -2.585% 21.603%
iShares Nasdaq 100 -3.301% 1.620% 11.248%
iShares Nikkei 225® -4.194% 4.289% 18.788%
iShares S&P 500 -1.866% 0.992% 6.273%

Comments by Citigroup_Inc_ for this prediction

In the thread Catalyst Pharmaceutical Partners Inc diskutieren
Prediction Buy
Perf. (%) 26.78%
Target price 24.737
Change
Ends at 14.03.25

Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $27.00 price target on the stock.
Ratings data for CPRX provided by MarketBeat

Citigroup Inc. 
0
Report Share
14.03.24
In the thread Trading Catalyst Pharmaceutical Partners Inc
Prediction Buy
Perf. (%) 26.78%
Target price 24.737
Change
Ends at 14.03.25

Die von Citigroup_Inc_ gewählte maximale Laufzeit wurde überschritten

Citigroup Inc. 
0
Report Share
15.03.25

Current prediction by Citigroup_Inc_ for Catalyst Pharmaceutical Partners Inc

buy
Catalyst Pharmaceutical Partners Inc

Start price
Target price
Perf. (%)
€18.50
07.11.25
€28.60
07.11.26
0.00%
07.11.25

Citigroup Inc. 
07.11.25 50%